AOHC Fenbendazole Calculator for Cancer & Non-Cancer
Tablet-dose calculator based on real patient experiences. Cancer protocols: 222mg-2000mg daily; Non-cancer: 500-700mg daily. Strictly educational—requires medical supervision and liver monitoring.
Key Takeaways: Cancer patients report using 222mg-2000mg daily with
regular liver monitoring. NOT FDA-approved for humans. Requires medical supervision due to liver toxicity risk and
potential for rapid cancer progression in some cases.
Inputs
Joe Tippens Basic (222mg)
Aggressive Protocol (444mg)
High Dose (1000mg)
Max Dose (2000mg)
Based on real patient experiences. Higher doses require strict medical
supervision.
Body weight (numeric).
Planned Dose
Available tablet strengths
Results
Total mg per dose (target)—
Protocol—
Weight basis—
Requires liver function monitoring (ALT, AST) every 2-4 weeks. Stop if enzymes elevated.
Tablet combinations
No target yet.
Take with fatty food (coconut oil, eggs) for better absorption.
Critical safety notice
This tool is strictly educational. Fenbendazole is NOT FDA-approved for human use.
- Cancer protocols: 222mg-2000mg daily based on patient reports. Requires medical supervision.
- Serious risks: Liver injury, rapid cancer progression in some cases, bone marrow suppression at high doses.
- Monitoring required: Liver function tests every 2-4 weeks. Stop if ALT/AST elevated.
- Drug interactions: May interact with certain medications.
References & Patient Experiences
| Protocol | Dosage & Source |
|---|---|
| Joe Tippens Basic | 222 mg daily, 3 days on/4 days off. Complete remissions reported. [PMC Case Series 2025, Fenbendazole.org 2025][web:33][web:36] |
| Joe Tippens Modified | 222 mg daily continuous. No breaks. [Fenbendazole.org Protocol Guide][web:36] |
| High-Dose Protocols | 444mg-2000mg daily reported by cancer patients [HealNavigator Clinical Experience 2025][web:12] |
| Safety Data | Albendazole (similar drug): max tolerated 2400mg daily [Cancer Choices Safety Review 2025][web:21] |